Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 26, 2012

View Archived Issues

Bayer presents promising results from phase III studies of riociguat

Enlivex's lead product protects against GVHD in bone marrow transplantation

SP-333 demonstrates efficacy as treatment for gastrointestinal diseases

Bayer Schering Pharma prepares new agents for cancer

French group discloses novel agents for bone cancer

Novel potassium channel blockers presented by Xention

Swiss and German scientists synthesize new S1P receptor agonists

SJT Molecular Research divulges new agents for metabolic syndrome

Ares Trading discloses novel chemokine receptor ligands

Fujifilm Kyowa Kirin Biologics plans to develop bevacizumab biosimilar

SymBio completes recruitment in Japanese phase II study of antiemetic patch

COLTHERES consortium reports novel approaches to colon cancer therapy

Sosei confirms MAA filing of COPD treatment

New IL-1 receptor antagonist may ameliorate intestinal inflammation

Eisai signs agreement with Brazilian health agency for malaria and neglected tropical diseases

DepoVax found to enhance effect of investigational cocaine vaccine

Ezose enters collaboration to discover diagnostic biomarkers for multiple sclerosis

Qiagen and Bayer to collaborate on companion diagnostics for targeted anticancer therapies

Durata Therapeutics achieves milestone in phase III DISCOVER 2 trial

Prodrug formulated to deliver simvastatin to skeletal tissue

Biotecnol and PolyTherics to develop Tribody antibody drug conjugates

ZIOPHARM Oncology advances Ad-RTS-IL-12 to phase II

United Therapeutics receives complete response letter for oral treprostinil

FDA accepts NDA filing for controlled-release misoprostol vaginal insert

Biken and Mitsubishi Tanabe set to launch Tetrabik in Japan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Anticancer drug exerts potent HIV antiviral effects
BioWorld Science
A new isoform of proliferating cell nuclear antigen (PCNA) – cancer-associated PCNA (caPCNA) – that is specifically expressed in cancer tissues has been reported....